ghk cu nasal spray side effects GHK-Cu Support Compounded GHK-Cu Nasal Spray —

Topical and intraperitoneal addition of TB4 increased re-epithelialisation by 42% over saline controls at day 4, and by up to 61% at day 7 post-wounding

Human trials have predominantly used topical or brief systemic dosing, and tolerability is overall reported to be good

It is available as a research peptide and is also found in some cosmetic formulations

The panel will review the evidence supporting the use of these peptides for specific indications, including ulcerative colitis, wound healing, obesity and migraines

Studies on dermal fibroblasts have documented up to 70% increases in collagen I production at optimal concentrations of 1 nanomolar

There was a complete absence of toxic outcomes or adverse side effects in both trials